CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
9.95
+0.44 (4.63%)
At close: Oct 17, 2025, 4:00 PM EDT
10.14
+0.19 (1.91%)
After-hours: Oct 17, 2025, 5:44 PM EDT
CVRx, Inc. Market Cap
CVRx, Inc. has a market cap or net worth of $260.21 million as of October 17, 2025. Its market cap has increased by 37.45% in one year.
Market Cap
260.21M
Enterprise Value
215.73M
1-Year Change
37.45%
Ranking
Category
Stock Price
$9.95
Market Cap Chart
Since the IPO on June 30, 2021, CVRx, Inc.'s market cap has decreased from $347.31M to $260.21M, a decrease of -25.08%. That is a compound annual growth rate of -6.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 260.21M | -15.36% |
| Dec 31, 2024 | 307.42M | -53.03% |
| Dec 29, 2023 | 654.44M | 73.26% |
| Dec 30, 2022 | 377.72M | 51.75% |
| Dec 31, 2021 | 248.90M | -28.33% |
| Jun 30, 2021 | 347.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |